TOI Oncology Institute, Inc. Insider Trading

10% Owner Chernett Jorey bought 15,000 TOI shares at $5.85 on 2026-07-10; holdings now 10.63M shares

Chernett Jorey, a 10% owner, purchased 15,000 shares at $5.85 on 2026-07-10, increasing holdings to 10,630,858 shares. The stock has appreciated 12.2% over the prior 30 days and 76.3% over 90 days, currently trading at $5.96. Jorey's cross-ticker track record shows 20 prior buys with an 80.00% 90-day win rate and average 90-day returns of +27.6%, though at TOI specifically his 5 prior trades remain mostly unmeasured beyond 30 days. The company reported $147,441,000.00 in latest-quarter revenue with 27.8% annual revenue growth, but remains unprofitable with $-2,492,000.00 net income in the most recent quarter; this open-market accumulation by a major shareholder occurs against a backdrop of strong price momentum but ongoing losses.

10% Owner Chernett Jorey buys 18,000 shares of TOI at $5.02; fifth consecutive buy in 7 weeks with 30-day returns averaging +29%.

Chernett Jorey, a 10% owner, purchased 18,000 shares at $5.02 on 2026-06-23, extending a recent pattern of aggressive accumulation at this ticker. Over the prior 7 weeks (2026-04-09 through 2026-06-04), Jorey executed 4 prior purchases at TOI, each yielding positive 30-day returns: +29.0%, +29.9%, +28.6%, and +29.2%. The current acquisition follows the same cadence. At the same-ticker level, these five cumulative buys demonstrate sustained conviction, and the consistent 30-day performance suggests market receptivity. However, the company remains unprofitable with net income of $-2.5M in the latest quarter, despite 27.8% annual revenue growth—a risk factor for a major holder accumulating shares at current levels. The stock trades at $5.27 today, 5.6% below its 52-week high of $5.58, and has gained 14.8% over 30 days; whether this momentum persists beyond the typical 30-day window is unknown, as no 90-day outcomes are yet measurable for any of these recent trades.

10% Owner Chernett Jorey purchases 12,000 TOI shares at $4.75; prior 5 trades at ticker all posted positive 90d returns.

Chernett Jorey, holding 10.58M shares post-transaction, purchased 12,000 shares at $4.75 on 2026-06-04 for $57.0K. His prior 5 trades at TOI showed consistent positive 90-day returns: 16.5%, 17.0%, 15.9%, 29.0%, and 60.1%, with all five purchases gaining value over the 90-day window. His cross-ticker buy track record spans 20 prior transactions with average 90d return +42.8% and a 90d win rate of 90.00%. The current stock price of $4.88 sits 0.4% below the 52-week high of $4.90, having risen 28.4% over 30 days and 75.5% over 90 days. Despite this momentum, the company reported net income of $-2.5M over its most recent full fiscal year and remains unprofitable, though annual revenue growth reached +27.8%.

10% Owner Chernett Jorey purchases 38,500 shares at $4.07 avg; stock +18.2% in 30d, +60.0% in 90d

Chernett Jorey, a 10% owner, executed 2 separate purchases totaling 38,500 shares for $156,595.00 at a blended average price of $4.07 on 2026-05-19 and 2026-05-20, increasing his holdings from 10.53M to 10.57M shares. The timing of this purchase aligns with a notable price recovery: the stock has risen 18.2% over 30 days and 60.0% over 90 days, and is currently trading at $4.16, only 14.8% below its 52-week high of $4.88. His 5 prior purchases at this ticker all showed positive 90-day returns (+3.2% to +38.5%), establishing a consistent pattern of prior trades that eventually gained. The company reported quarterly revenue of $147.4M with annual growth of +27.8%, though it remains unprofitable with $-2.5M net income in the latest quarter. This buy by a major shareholder during a period of stock appreciation warrants observation given his track record at this ticker.

10% owner Chernett Jorey purchased 30,000 shares of TOI at $4.09 on 2026-05-19; 5 of 5 prior TOI buys showed positive 90d returns

Chernett Jorey, a 10% owner, purchased 30,000 shares at $4.09, bringing holdings to 10,529,358 shares and raising his stake slightly by 30,000 shares. This represents his sixth purchase at TOI over a concentrated period; across his prior five TOI trades, all five generated positive 90-day returns (ranging from +22.4% to +38.5%), indicating a pattern of consistent timing accuracy at this ticker. The company carries meaningful headwinds—it is unprofitable (net income of $-2,492,000 on revenue of $147,441,000) and the stock trades 14.8% below its 52-week high—yet the insider continues to accumulate. The 30-day momentum is strong at +18.2%, and the 90-day move of +60.0% suggests near-term strength, but the transaction's significance derives from whether the insider's historically well-timed pattern at TOI persists and whether an unprofitable but revenue-growing business ($147,441,000 latest quarter, +27.8% annual growth) can narrow losses in the medium term.

10% owner Chernett Jorey buys 20,000 TOI shares at $3.10 (4th trade in 10 days); stock up 16.2% in 30 days, down 6.5% in 90 days from purchase

Chernett Jorey, a 10% shareholder, purchased 20,000 shares at $3.10 on 2026-04-09, extending a cluster of five buy transactions over a 20-day period (2026-03-17 through 2026-04-09). The company is unprofitable (net income $-16,504,000 in the latest quarter) despite strong top-line growth of +27.8% year-over-year and a market cap of $326.2M. The stock has recovered 16.2% in the 30 days since this purchase but remains down 6.5% over 90 days, trading at $3.30 against a 52-week high of $4.75. The rapid succession of buys during a period of volatility and the 10% ownership stake warrant monitoring for any public announcements or strategic context that might illuminate the timing and conviction behind these purchases.

10% owner Chernett Jorey buys 27,429 shares of TOI at $2.96; 5 consecutive buy days in March, stock now -40.4% from 52-week high.

Chernett Jorey, a 10% owner, purchased 27,429 shares at $2.96 on 2026-03-27 as part of an intensive buying sequence—five separate purchases across consecutive trading days (2026-03-16 through 2026-03-27). This concentrated accumulation occurred as the stock declined -22.5% over 90 days and currently trades -40.4% from its 52-week high of $4.75. The company generates $136.6M in quarterly revenue with +27.8% annual growth, yet remains unprofitable with net income of $-16.5M over its most recent full fiscal year, creating a tension between operational momentum and financial losses. The rapid-fire purchasing pattern during a steep drawdown, combined with the substantial size of the 10.48M share position (now increased by 27,429 shares), warrants scrutiny of whether the insider views current valuations as attractive or whether market conditions present elevated execution risk for a loss-making operation despite strong top-line expansion.

10% Owner Chernett Jorey purchased 50,000 shares of TOI at $3.15 on 2026-03-26, bringing holdings to 10,451,929 shares.

Chernett Jorey, a 10% shareholder, purchased 50,000 shares at $3.15 on 2026-03-26, adding to a position already representing substantial ownership. The transaction is notable given the company's unprofitable status with net income of $-16.5M on revenue of $136.6M (latest quarter), though annual revenue growth reached +27.8%. The stock currently trades at $2.96, representing a -37.7% decline from its 52-week high of $4.75, placing this purchase at a significant premium to current market price. Most significantly, this purchase is one of five rapid-succession buys at TOI within a 10-day window (2026-03-16 through 2026-03-27), totaling approximately 200,000 shares accumulated in concentrated timeframe, suggesting a deliberate accumulation pattern by this major shareholder during a period of extended stock weakness.

10% Owner Chernett Jorey purchases 125,000 shares of TOI for $388.8K; fourth buy in 8 days as stock rebounds +22.4% in 30 days.

Chernett Jorey, a 10% shareholder, acquired 125,000 shares at $3.11 on 2026-03-24, the fourth separate purchase in an 8-day window (2026-03-13 through 2026-03-24). The timing follows a sharp 30-day rally of +22.4%, though the stock remains -34.3% below its 52-week high of $4.75 and has declined -11.4% over 90 days. The company posted strong revenue growth of +27.8% year-over-year but reported negative net income of $-16.5M in the latest quarter and remained unprofitable over its most recent full fiscal year. The rapid succession of purchases by a significant shareholder in an unprofitable biotech-adjacent company during a period of price volatility warrants scrutiny of whether these transactions reflect informed views on near-term catalysts or represent support for a distressed equity.

10% Owner Chernett Jorey buys 25,000 shares of TOI at $3.35; stock at $3.21, -32.4% from 52-week high

Chernett Jorey, a 10% owner, purchased 25,000 shares at $3.35 on 2026-03-20, expanding holdings from 10,251,929 to 10,276,929 shares. This purchase occurs in the context of recent volatility: the stock has declined 5.0% over 90 days and is currently trading 32.4% below its 52-week high of $4.75, though it has recovered 25.4% over the past 30 days. Jorey's same-ticker purchase history shows three consecutive buys on 2026-03-13, 2026-03-16, and 2026-03-17, suggesting accumulated buying activity within a narrow window, though outcomes on these recent purchases are not yet measurable. The company remains unprofitable with net income of -$16,504,000 on revenue of $136,564,000, but is growing at +27.8% annually, presenting a classic unprofitable-growth-stage profile. The significance is moderate given the stock's substantial distance from recent highs and the lack of measurable outcomes from prior same-ticker trades.